https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-07-01 / Curr Oncol Rep 2006 Jul;8(4):305-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-07-01 / Curr Oncol Rep 2006 Jul;8(4):305-92006-07-01 00:00:002006-07-01 00:00:00The role of hyperthermia in combined treatment in the management of soft tissue sarcoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-01 / Int J Hyperthermia 2006 May;22(3):235-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-01 / Int J Hyperthermia 2006 May;22(3):235-92006-05-01 00:00:002019-02-15 09:37:53High-risk soft tissue sarcoma: clinical trial and hyperthermia combined chemotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-05-01 / Klin Padiatr 2004 May-Jun;216(3):176-82
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-05-01 / Klin Padiatr 2004 May-Jun;216(3):176-822004-05-01 00:00:002019-02-15 09:12:31Characterization of CD34+ progenitor-derived dendritic cells pulsed with tumor cell lysate for a vaccination strategy in children with malignant solid tumors and a poor prognosis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-03-01 / Eksp. Onkol. 2004 Mar;26(1):67-70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-03-01 / Eksp. Onkol. 2004 Mar;26(1):67-702004-03-01 00:00:002004-03-01 00:00:00Enhancement of antitumor response to sarcoma 45 in rats by combination of whole-body hyperthermia and interleukin-2
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-11-01 / Klin Padiatr 2003 Nov-Dec;215(6):303-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-11-01 / Klin Padiatr 2003 Nov-Dec;215(6):303-92003-11-01 00:00:002003-11-01 00:00:00An approach for cure: PEI-chemotherapy and regional deep hyperthermia in children and adolescents with unresectable malignant tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-01-01 / Oncology 2003;65 Suppl 2:76-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-01-01 / Oncology 2003;65 Suppl 2:76-92003-01-01 00:00:002003-01-01 00:00:00Ifosfamide with regional hyperthermia in soft-tissue sarcomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-01-01 / Oncology 2003;64(4):312-21
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-01-01 / Oncology 2003;64(4):312-212003-01-01 00:00:002003-01-01 00:00:00A Systemic Hyperthermia Oncologic Working Group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-12-01 / Cancer Res. 2001 Dec;61(23):8513-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-12-01 / Cancer Res. 2001 Dec;61(23):8513-92001-12-01 00:00:002019-02-15 08:53:19Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-09-01 / Eur. J. Cancer 2001 Sep;37(13):1599-608
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-09-01 / Eur. J. Cancer 2001 Sep;37(13):1599-6082001-09-01 00:00:002001-09-01 00:00:00Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-09-01 / Int J Hyperthermia 2001 Sep-Oct;17(5):428-38
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-09-01 / Int J Hyperthermia 2001 Sep-Oct;17(5):428-382001-09-01 00:00:002001-09-01 00:00:00Effect of whole body hyperthermia on radiation therapy of transplanted fibrosarcoma in Swiss mice
